Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
The mRNA Pivot: Moderna Navigates Regulatory Headwinds and Tariff Turmoil in a Volatile 2026 Biotech Landscape
Via MarketMinute
Topics Economy Intellectual Property World Trade
Tickers ABUS BNTX GSK JPM MRK MRNA
Exposures COVID-19 Intellectual Property Interest Rates
News headline image
Shanghai Apolo Medical Technology Co., Ltd. Shines in the Medical and Aesthetic Industries.
Via Get News
Topics Artificial Intelligence Supply Chain
Exposures Artificial Intelligence Product Safety Supply Chain
News headline image
OpenAI Bridges the Gap Between AI and Medicine with the Launch of “ChatGPT Health”
Via TokenRing AI
Topics Artificial Intelligence
Tickers AAPL CART GOOGL MSFT NVDA PTON
Exposures Artificial Intelligence Product Safety
BEAM Stock In Focus As FDA Alignment Wins William Blair’s Praise ↗
Via Stocktwits
Tickers ARKG ARKK BEAM VB
Exposures Product Safety
News headline image
Life Imaging Fla Calls for a Shift From Waiting to Knowing in Personal Health Decisions
Via Get News
Topics Death
Exposures Death Product Safety
News headline image
Why Did LVLU Stock More Than Double Today? ↗
Via Stocktwits
Tickers LVLU VTI VXF
Exposures Product Safety
News headline image
CCHR Says Mounting Evidence of Persistent Sexual Dysfunction From Antidepressants Demands FDA Action
Via PRLog
Exposures Product Safety
News headline image
REMSleep Outlines Q1 2026 Commercial Strategy: Expanded FDA Application, B2B Launch Prep, and Institutional Market Entry
Via NewMediaWire
Tickers ASX:RMD RMSL
Exposures Product Safety
REMSleep Outlines Q1 2026 Commercial Strategy: Expanded FDA Application, B2B Launch Prep, and Institutional Market Entry
Via TheNewswire.com
Tickers ASX:RMD RMSL
Exposures Product Safety
News headline image
Beam Soars Nearly 30% As FDA Signs Off On Its Ambitious Gene-Editing Plan ↗
Via Investor's Business Daily
Exposures Product Safety
News headline image
20,000 Reasons to Consider Selling Rivian Stock Here
Via Barchart.com
Topics Electric Vehicles Product Recall Supply Chain
Tickers AMZN VLKAF VWAGY VWAPY
Exposures Electric Vehicles Legal Product Safety
News headline image
ATRA Stock Nearly Halves In Value After FDA Refuses Approval For Immunotherapy: Retail Sees ‘Big Fight Back’ ↗
Via Stocktwits
Tickers ATRA IWC VTI
Exposures Product Safety
News headline image
From Silicon to Syringes: Nvidia’s AI Dominance Solidified Through Landmark Eli Lilly Alliance
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Tickers ILMN JNJ JPM LLY NVDA NVO
Exposures Artificial Intelligence Intellectual Property Product Safety
News headline image
The AI-Bio Convergence: Lilly and Nvidia Kick Off JPM26 with Landmark $1 Billion Alliance
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
Tickers ABBV BMY JPM LLY MRK NVDA
Exposures Artificial Intelligence Intellectual Property Product Safety
News headline image
The Global Dimension of Larry Gaiters: Media, Spirituality, and the Revolution of Conscience
Via Get News
Topics Product Recall
Exposures Legal Product Safety
News headline image
The Convergence of Silicon and Science: Eli Lilly and Nvidia Unveil $1 Billion AI Co-Innovation Lab at JPM26
Via MarketMinute
Topics Artificial Intelligence
Tickers AMGN GOOGL JPM LLY MSFT NVDA
Exposures Artificial Intelligence Product Safety
News headline image
CCHR Calls on FDA to Act as Evidence Mounts Linking Antidepressants to Persistent Sexual Dysfunction
Via Send2Press
Exposures Product Safety
News headline image
uniQure N.V. Investigation Notice: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm
Via NewMediaWire
Tickers QURE
Exposures Product Safety
News headline image
Rivian Shares Stumble as Massive Suspension Recall Collides with Insider Selling Jitters
Via MarketMinute
Topics Artificial Intelligence Earnings Electric Vehicles
Tickers AMZN F LCID RIVN TSLA UBER
Exposures Artificial Intelligence Electric Vehicles Financial
News headline image
uniQure N.V. Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm
Via NewMediaWire
Tickers QURE
Exposures Product Safety
News headline image
uniQure N.V. Investigation: Kessler Topaz Meltzer &amp; Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm
Via TheNewswire.com
Tickers QURE
Exposures Product Safety
Crisis to connection: How promotional products build community loyalty
Via AB Newswire
Topics Economy Product Recall
Exposures Legal Product Safety Supply Chain
News headline image
The Era of Interception: How Mayo Clinic’s AI is Predicting Disease Years Before the First Symptom
Via TokenRing AI
Topics Artificial Intelligence
Tickers GOOGL MSFT NVDA SNBR
Exposures Artificial Intelligence Product Safety
News headline image
uniQure Stock Jumps After Scheduling FDA Type A Meeting For AMT‑130 Approval Pathway ↗
Via Benzinga
Tickers QURE
Exposures Product Safety
News headline image
Bad News For Competitor Turns Into Big Win For ARS Pharma Stock ↗
Via Benzinga
Exposures Product Safety
BioMedNewsBreaks – FDA Clearance for HeartBeam Inc. (NASDAQ: BEAT) Highlighted in Medical Device Approvals Roundup
Via Investor Brand Network
Topics Intellectual Property
Tickers BEAT
Exposures Intellectual Property Product Safety
News headline image
Cashing In at the Peak: Olema Pharmaceuticals Insiders Sell $8 Million in Stock After 300% Surge
Via MarketMinute
Tickers AZN GS JEF LLY OLMA PFE
Exposures Product Safety
News headline image
The Great Pricing Pivot: Novo Nordisk Launches Wegovy Pill in Bid to Reclaim US Market Dominance
Via MarketMinute
Topics Economy
Tickers GS LLY NVO PFE
Exposures Product Safety Supply Chain
News headline image
Aquestive Stock Slides After FDA Flags Issues With Allergy Drug Application ↗
Via Benzinga
Exposures Product Safety
News headline image
The Trillion-Dollar Pharmacist: A 2026 Deep Dive into Eli Lilly (LLY)
Via PredictStreet
Topics Earnings Economy Intellectual Property
Tickers AMGN BIIB BLK JNJ LLY NVO
Exposures Economy Financial Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.